These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 21841523)

  • 1. Neurosurgical management and prognosis of patients with glioblastoma that progresses during bevacizumab treatment.
    Clark AJ; Lamborn KR; Butowski NA; Chang SM; Prados MD; Clarke JL; McDermott MW; Parsa AT; Berger MS; Aghi MK
    Neurosurgery; 2012 Feb; 70(2):361-70. PubMed ID: 21841523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of bevacizumab chemotherapy on craniotomy wound healing.
    Clark AJ; Butowski NA; Chang SM; Prados MD; Clarke J; Polley MY; Sughrue ME; McDermott MW; Parsa AT; Berger MS; Aghi MK
    J Neurosurg; 2011 Jun; 114(6):1609-16. PubMed ID: 21142749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glioblastoma in the elderly: the impact of advanced age on treatment and survival.
    Mariniello G; Peca C; De Caro Mdel B; Giamundo A; Donzelli R; Maiuri F
    J Neurol Surg A Cent Eur Neurosurg; 2014 Jul; 75(4):276-81. PubMed ID: 24390930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of reoperation for recurrent glioblastoma.
    Dirks P; Bernstein M; Muller PJ; Tucker WS
    Can J Surg; 1993 Jun; 36(3):271-5. PubMed ID: 8391917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Safety of Surgery in Elderly Patients with Primary and Recurrent Glioblastoma.
    D'Amico RS; Cloney MB; Sonabend AM; Zacharia B; Nazarian MN; Iwamoto FM; Sisti MB; Bruce JN; McKhann GM
    World Neurosurg; 2015 Oct; 84(4):913-9. PubMed ID: 26074434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RIBBON-1: randomized, double-blind, placebo-controlled, phase III trial of chemotherapy with or without bevacizumab for first-line treatment of human epidermal growth factor receptor 2-negative, locally recurrent or metastatic breast cancer.
    Robert NJ; Diéras V; Glaspy J; Brufsky AM; Bondarenko I; Lipatov ON; Perez EA; Yardley DA; Chan SY; Zhou X; Phan SC; O'Shaughnessy J
    J Clin Oncol; 2011 Apr; 29(10):1252-60. PubMed ID: 21383283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An extent of resection threshold for recurrent glioblastoma and its risk for neurological morbidity.
    Oppenlander ME; Wolf AB; Snyder LA; Bina R; Wilson JR; Coons SW; Ashby LS; Brachman D; Nakaji P; Porter RW; Smith KA; Spetzler RF; Sanai N
    J Neurosurg; 2014 Apr; 120(4):846-53. PubMed ID: 24484232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: a 10-year institutional experience.
    Attenello FJ; Mukherjee D; Datoo G; McGirt MJ; Bohan E; Weingart JD; Olivi A; Quinones-Hinojosa A; Brem H
    Ann Surg Oncol; 2008 Oct; 15(10):2887-93. PubMed ID: 18636295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple craniotomies in the management of multifocal and multicentric glioblastoma. Clinical article.
    Hassaneen W; Levine NB; Suki D; Salaskar AL; de Moura Lima A; McCutcheon IE; Prabhu SS; Lang FF; DeMonte F; Rao G; Weinberg JS; Wildrick DM; Aldape KD; Sawaya R
    J Neurosurg; 2011 Mar; 114(3):576-84. PubMed ID: 20690813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. γ knife surgery versus reoperation for recurrent glioblastoma multiforme.
    Skeie BS; Enger PØ; Brøgger J; Ganz JC; Thorsen F; Heggdal JI; Pedersen PH
    World Neurosurg; 2012 Dec; 78(6):658-69. PubMed ID: 22484078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salvage therapy in patients with glioblastoma: is there any benefit?
    Hau P; Baumgart U; Pfeifer K; Bock A; Jauch T; Dietrich J; Fabel K; Grauer O; Wismeth C; Klinkhammer-Schalke M; Allgäuer M; Schuierer G; Koch H; Schlaier J; Ulrich W; Brawanski A; Bogdahn U; Steinbrecher A
    Cancer; 2003 Dec; 98(12):2678-86. PubMed ID: 14669289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value and kinetics of circulating endothelial cells in patients with recurrent glioblastoma randomised to bevacizumab plus lomustine, bevacizumab single agent or lomustine single agent. A report from the Dutch Neuro-Oncology Group BELOB trial.
    Beije N; Kraan J; Taal W; van der Holt B; Oosterkamp HM; Walenkamp AM; Beerepoot L; Hanse M; van Linde ME; Otten A; Vernhout RM; de Vos FY; Gratama JW; Sleijfer S; van den Bent MJ
    Br J Cancer; 2015 Jul; 113(2):226-31. PubMed ID: 26042933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reoperation for Recurrent Glioblastoma and Its Association With Survival Benefit.
    Tully PA; Gogos AJ; Love C; Liew D; Drummond KJ; Morokoff AP
    Neurosurgery; 2016 Nov; 79(5):678-689. PubMed ID: 27409404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re-do Craniotomy for Recurrent Grade IV Glioblastomas: Impact and Outcomes from the National Neuroscience Institute Singapore.
    Chen MW; Morsy AA; Liang S; Ng WH
    World Neurosurg; 2016 Mar; 87():439-45. PubMed ID: 26585720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.
    Chan TA; Weingart JD; Parisi M; Hughes MA; Olivi A; Borzillary S; Alahakone D; Detorie NA; Wharam MD; Kleinberg L
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1133-9. PubMed ID: 15990019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of clinical prognostic factors on survival in patients with glioblastoma.
    Tugcu B; Postalci LS; Gunaldi O; Tanriverdi O; Akdemir H
    Turk Neurosurg; 2010 Apr; 20(2):117-25. PubMed ID: 20401838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term survival in patients with recurrent glioblastoma treated with bevacizumab: a multicentric retrospective study.
    Morisse MC; Etienne-Selloum N; Bello-Roufai D; Blonski M; Taillandier L; Lorgis V; Noël G; Ahle G; Durán-Peña A; Boone M; Chauffert B
    J Neurooncol; 2019 Sep; 144(2):419-426. PubMed ID: 31325146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of surgery on survival after progression of glioblastoma: A retrospective cohort analysis of a contemporary patient population.
    Sastry RA; Shankar GM; Gerstner ER; Curry WT
    J Clin Neurosci; 2018 Jul; 53():41-47. PubMed ID: 29680441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overall survival, prognostic factors, and repeated surgery in a consecutive series of 516 patients with glioblastoma multiforme.
    Helseth R; Helseth E; Johannesen TB; Langberg CW; Lote K; Rønning P; Scheie D; Vik A; Meling TR
    Acta Neurol Scand; 2010 Sep; 122(3):159-67. PubMed ID: 20298491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glioblastoma multiforme-report of 267 cases treated at a single institution.
    Stark AM; Nabavi A; Mehdorn HM; Blömer U
    Surg Neurol; 2005 Feb; 63(2):162-9; discussion 169. PubMed ID: 15680662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.